Dr. Takeki Uehara received his DVM degree from the Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Japan, in 2002. He then joined SHIONOGI, where he has worked for over 20 years.
As a research scientist, Dr. Uehara has authored multiple publications and, in 2008, earned a PhD in Veterinary Medicine from Osaka Prefecture University. His research career includes serving as a visiting research scientist in Public Health at the University of North Carolina at Chapel Hill.
In SHIONOGI’s Development Department, Dr. Uehara serves as the Global Project Leader for baloxavir and ensitrelvir, contributing to the successful development of these antivirals. Currently, he holds the position of Corporate Officer, Senior VP at Shionogi, serving as the Global Head of Development and Regulatory Affairs.
Dr. Uehara has published approximately 100 peer-reviewed papers and has organized international workshops and educational courses at several global conferences.